Democratic Republic of Congo vs Myanmar: Average cost of drugs for extensively drug-resistant tuberculosis
Democratic Republic of Congo
1,102 constant 2022 US$
in 2024
Myanmar
963 constant 2022 US$
in 2024
Democratic Republic of Congo rank
41st
Myanmar rank
43rd
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Democratic Republic of Congo
- Myanmar
How they compare
Democratic Republic of Congo currently reports 1,102 constant 2022 US$ against 963 constant 2022 US$ in Myanmar, a difference of 139 constant 2022 US$.
That makes Democratic Republic of Congo's figure about 1.1 times Myanmar's.
The two have swapped places 3 times across 8 shared years of data; in 2017 it was Myanmar ahead.
Democratic Republic of Congo ranks 41st and Myanmar ranks 43rd of 56 countries.
Across the 2 decades both report, Democratic Republic of Congo averaged higher in 1 and Myanmar in 1.
Head to head by decade
| Decade | Democratic Republic of Congo | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,113 constant 2022 US$ | 7,630 constant 2022 US$ | 1,517 constant 2022 US$ | Myanmar |
| 2020s | 2,939 constant 2022 US$ | 2,689 constant 2022 US$ | 250.6 constant 2022 US$ | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Democratic Republic of Congo or Myanmar?
- Democratic Republic of Congo, at 1,102 constant 2022 US$ against 963 constant 2022 US$ in Myanmar as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Democratic Republic of Congo and Myanmar?
- 139 constant 2022 US$, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Myanmar?
- 8 years are reported by both, from 2017 to 2024.
- How do Democratic Republic of Congo and Myanmar rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Democratic Republic of Congo ranks 41st and Myanmar ranks 43rd of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.